FURQAN RAJA: Open Payments
NPI 1710210232 · TAFT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $275 |
| Vanda Pharmaceuticals Inc. | 4 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $252 |
| Otsuka America Pharmaceutical, Inc. | 2 | $235 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $14 |
Products named: COBENFY, FANAPT, CAPLYTA, ABILIFY MAINTENA, INGREZZA, Wegovy.
Industry payments across CA — which companies pay providers there.
